BLS vs CGS

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

BLS

BLSPHARMA FPO [BLS]

56MEDIUM

CGS

COGSTATE FPO [CGS]

57MEDIUM

Score Breakdown

BLS CGS
Technical
91
61
Catalyst
54
55
Sentiment
50
50
Fundamental
100
99
Momentum
86
64
Risk Gate
50
45

Key Metrics

BLS Metric CGS
$249.9MMarket Cap$523.4M
310KAvg Volume (20d)699K
+0.0%Short Interest+0.0%
$1.20052-Week High$3.230
$0.33052-Week Low$1.690
+0.4%Daily Change-0.3%
$1.110Reference Price$3.070
+66.1%ROE+22.5%
+18.7%Profit Margin+19.5%

Active Signals

BLS Signals

RSI is running hot — overbought territory, so expect some pullback risk
MACD momentum is picking up steam
Trading above both moving averages — the trend is your friend here
Volume surging at 3.4x normal while price climbs — real buying conviction behind this move
RSI is overbought but volume confirms it — this could be genuine momentum, not just froth
On a tear — up 20.7% over the last 5 days
Beating the Small Ords index — relative strength of 1.25, so it's outpacing the pack
Volatility is expanding fast — choppy price action, so buckle up

CGS Signals

Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Moderate P/S ratio (8.6x)
Moderate revenue growth (+16%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Near 52-week high (90% of range)

Ask Scout AI to compare BLS and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs IIQ →CGS vs LDX →CGS vs LGP →EYE vs SOM →NOX vs RHT →
BLS Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).